Table 1
Repository sites of the Quebec Respiratory Health Network Biobank.
| Site | Recruitment | Years active | Current researchers in charge |
|---|---|---|---|
| Institut universitaire de cardiologie et de pneumologie de Québec (IUCPQ) | active | 1998–ongoing | François Maltais Philippe Joubert |
| Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM) | active | 2011–ongoing | Emmanuelle Brochiero |
| Meakins-Christie Laboratories | active | 1998–ongoing | Simon Rousseau Anne-Marie Lauzon |
| Université du Québec à Chicoutimi (UQAC) | active | 2005–ongoing | Catherine Laprise |
| Centre hospitalier universitaire de Sherbrooke (CHUS) | inactive | 1998–2006 | NA |
| Centre hospitalier universitaire Sainte-Justine (CHUSJ) | development | 2017–ongoing | Sze Man Tse |

Figure 1
Cumulative number of patients (left panel) and samples (right panel) by medical condition in the Quebec Respiratory Health Network Biobank. COPD: Chronic obstructive pulmonary disease, ILD: Interstitial lung diseases, PAH: Pulmonary arterial hypertension.
Table 2
Stabilization, preservation and storage of biological samples.
| Type of samples | Stabilization/preservation | Type of long-term preservation | Storage temperature |
|---|---|---|---|
| Serum | Tubes are plain VACUTAINER® containing no anticoagulant | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| Plasma | Tubes with spray-coated K2EDTA | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| Buffy coat | Tubes with spray-coated K2EDTA | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| Tissue: Bronchial biopsies | 10% neutral buffered formalin 4% formaldehyde solution | Paraffin Embedded | Room temperature |
| Muscle biopsies Nasal polyp Nasal mucosa | Tissue microarrays (TMA) | ||
| Non-tumor and Tumor lung Parenchyma | OCT: Embedding medium for frozen tissue specimens | Ultra-low temperature freezers | –80°C |
| Mucus Uvula | Snap frozen in liquid nitrogen | Ultra-low temperature freezers | –80°C |
| Tissue from lung transplant Trachea | Glycol Methacrylate (GMA) embedding medium | Freezers | –20°C |
| Induced sputum supernatants | With or without antiprotease | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| Bronchoalveolar lavages supernatants | With or without antiprotease | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| DNA | DNA is eluted in Buffer AE, Qiagen | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| RNA | RNA is eluted in RNase-free water | Cryotube aliquots in ultra-low temperature freezers | –80°C |
| Lung primary cell cultures | DMSO | Liquid nitrogen tanks | –150°C –196°C |
Table 3
Clinical data collected by respiratory condition.
| Asthma | Lung cancer | COPD | Cystic fibrosis | Pulmonary hypertension | Interstitial diseases | ARDS | |
|---|---|---|---|---|---|---|---|
| Subject biobank ID # | |||||||
| Gender | |||||||
| Ethnicity | |||||||
| Age at time of visit | |||||||
| Height | |||||||
| Weight | |||||||
| BMI | |||||||
| Death | |||||||
| Visit type | |||||||
| Date of visit | |||||||
| Study name (if applicable) | |||||||
| Version of consent form | |||||||
| Smoking history | |||||||
| Type of subject (tailored to each specific condition) | |||||||
| Allergy (yes or no and details on respiratory allergens) | |||||||
| Age of onset | |||||||
| Year of diagnosis | |||||||
| Other diseases | |||||||
| Pulmonary function testing | |||||||
| Blood tests (tailored to each specific condition) | |||||||
| Medical tests (tailored to each specific condition) | |||||||
| Medication | |||||||
| Date of surgery | |||||||
| Investigation | |||||||
| Pathology | |||||||
| Postoperative follow-up |
[i] Grey shaded areas indicate that data are available.
Table 4
The number of subjects and samples by medical condition.
| # subjects | # samples | |
|---|---|---|
| Asthma | 2540 | 17701 |
| Lung cancer | 3712 | 29165 |
| COPD | 510 | 6715 |
| Cystic fibrosis | 335 | 409 |
| Lung transplant | 34 | 26 |
| Sleep apnea | 50 | 255 |
| Pulmonary arterial hypertension | 483 | 2237 |
| Interstitial lung diseases | 244 | 545 |
| Total | 7908 | 57053 |
| Sabrina Biardel | Coordinator of the Quebec RHN Biobank. |
| Christine Racine | Biobank manager at the IUCPQ. |
| Yvan Fortier | Database manager and Éric Rousseau is responsible for the database at the Laboratoire de Télématique Biomédicale (LTB) – CHUS. |
| Andrea Karen Mogas | Biobank manager at RI-MUHC/Meakins-Christie Laboratories. |
| Émilie Maillé | Biobank manager at the CRCHUM. |
| Emmanuelle Brochiero | Researcher in charge at the CRCHUM. |
| Anne-Marie Lauzon | Researcher in charge at the RI-MUHC/Meakins-Christie Laboratories. |
| François Maltais and Philippe Joubert | Researchers in charge at the IUCPQ. |
| Sze Man Tse | Researcher in charge at the CHU Sainte-Justine. |
| Catherine Laprise | Researcher in charge at UQAC. |
| Élyse Bissonnette | Director of the Quebec RHN and oversees the activities of the biobank. |
| Michel Laviolette | Founder and past Director of the Quebec RHN Biobank. |
| Yohan Bossé | Previous Director of the Quebec RHN Biobank and largely contributed to this manuscript. |
| Simon Rousseau | Director of the Quebec RHN Biobank. |
